Merck Closes Out Canadian Vioxx Claims For Up To $36.5M

Law360, New York (January 19, 2012, 7:49 PM EST) -- Merck & Co. Inc. will pay up to CA$36.9 million (US$36.5 million) to settle a series of Canadian class actions over its marketing of the painkiller Vioxx, which the drugmaker pulled from shelves in 2004 after studies showed the drug doubled the risk of stroke and heart attack.

The pharmaceutical giant will pay between CA$21.8 million and CA$36.9 million to resolve all Vioxx claims in Canada, Merck said. Claims by heart attack victims and their estates will be evaluated on a case-by-case basis, based on certain...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.